Fig. 4From: Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failureHEV-induced liver failure patients are associated with high plasma HMGB1 levels. A HMGB1 levels in progression stage of ALF (p-ALF) and ACLF (p-ACLF) were significantly increased compared with Healthy Controls or AVH patients; B, C HMGB1 levels were correlated with SOD levels. *P < 0.05, **P < 0.01Back to article page